FindTrial
Sign In

Assessment of aortic valve disease by CT imaging

Assessment of aortic valve disease by CT imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000439
Enrollment
50
Registered
2010-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: multidetector CT imaging: 64 slice MDCT imaging using routine coronary imaging protocol Control Intervention1: transthoracic echocardiography: transthoracic echocardiography done either

Sponsors

JB Chemicals Pvt Ltd., 4th Floor, B-wing, Neelam Centre, behind cycle road, worli, Mumbai 400030
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: adults (>14years of age) with known or suspected aortic valvular dis aortic valvular disease due to either atherosclerotic, congenital or infective pathology

Exclusion criteria

Exclusion criteria: pediatric age group of 0 to 14years Known allergy to contrast media, high sr. creatine levels, patients with significantly poor cardiac function in whom ECG gating with beta-blockers or SA node inhibitors is not advisable.

Design outcomes

Primary

MeasureTime frame
obtaining aortic valve area by MDCTTimepoint: after CT imaging of the enitre study group comparison with 2D echo will be done.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactAlpa Bharati
alpabharati@hotmail.com02266986666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026